These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1512331
1. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia. Yeung-Lai-Wah JA, Murdock CJ, Boone J, Kerr CR. J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331 [Abstract] [Full Text] [Related]
2. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia. Mendes L, Podrid PJ, Fuchs T, Franklin S. J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457 [Abstract] [Full Text] [Related]
4. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN. Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166 [Abstract] [Full Text] [Related]
5. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS, Sugi K, Ohta M, Meesmann M, Ino T, Peter T, Mandel WJ. Am Heart J; 1986 Dec 01; 112(6):1173-83. PubMed ID: 3788764 [Abstract] [Full Text] [Related]
6. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU, Waxman HL, Kienzle MG, Cassidy DM, Marchlinski FE, Buxton AE, Josephson ME. J Am Coll Cardiol; 1984 Aug 01; 4(2):378-81. PubMed ID: 6736479 [Abstract] [Full Text] [Related]
10. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. Aguglia F, Gnecchi M, De Marzio P. Int J Cardiol; 1985 Mar 01; 7(3):303-6. PubMed ID: 2579918 [Abstract] [Full Text] [Related]
11. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide. Widerhorn J, Sager PT, Rahimtoola SH, Bhandari AK. Pacing Clin Electrophysiol; 1991 Mar 01; 14(3):420-6. PubMed ID: 1708872 [Abstract] [Full Text] [Related]
13. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia. Morgera T, Dreas L, Humar F, Maras P, Chersevani D, Camerini F. Int J Cardiol; 1991 May 01; 31(2):187-97. PubMed ID: 1869328 [Abstract] [Full Text] [Related]
14. Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time. Kus T, Dubuc M, Lambert C, Shenasa M. J Am Coll Cardiol; 1990 Nov 01; 16(5):1229-37. PubMed ID: 2229772 [Abstract] [Full Text] [Related]
15. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ, Easley AR, Mann DE. Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228 [Abstract] [Full Text] [Related]
16. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Toivonen L, Kadish A, Morady F. Circulation; 1991 Jul 01; 84(1):101-8. PubMed ID: 1905591 [Abstract] [Full Text] [Related]
17. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias. Budde T, Borggrefe M, Podczeck A, Martinez-Rubio A, Breithardt G. J Cardiovasc Pharmacol; 1991 Aug 01; 18(2):254-60. PubMed ID: 1717787 [Abstract] [Full Text] [Related]